Previous close | 6.52 |
Open | 6.81 |
Bid | 6.58 x N/A |
Ask | 6.89 x N/A |
Day's range | 6.81 - 6.81 |
52-week range | 2.93 - 7.58 |
Volume | |
Avg. volume | 848 |
Market cap | 247.74M |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | 16.61 |
EPS (TTM) | 0.41 |
Earnings date | N/A |
Forward dividend & yield | 0.26 (3.77%) |
Ex-dividend date | 28 May 2024 |
1y target est | N/A |
As global markets navigate through fluctuating inflation rates and interest rate adjustments, Sweden's market offers a unique blend of stability and opportunity. This environment sets the stage for considering dividend stocks, which can be appealing for those seeking potential income streams in a landscape marked by cautious monetary policies and economic indicators.
Zinzino, the global health and wellness brand from Scandinavia, has acquired, through a business asset acquisition, the rights to the distributor database and associated customer register, inventory, and intellectual property of the Luxembourg-based direct sales company Xellis. This is a further strategically important step in Zinzino's growth plans, focusing on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio markete
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM.